Noteworthy, during the preparation of this manuscript, Hung and colleagues reported that a Sema6C-targeted antibody promoted the proliferation of pancreatic carcinoma cells [10]; such findings led the authors to conclude on a tumor-suppressor activity of this semaphorin, seemingly in conflict with multiple lines of evidence presented here. This evidence concerns the gene SEMA6C and exocrine pancreatic carcinoma.